- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Indacaterol (QAB149)
Total 160 results
-
Taipei Medical University Shuang Ho HospitalUnknownChronic Obstructive Pulmonary DiseaseTaiwan
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Netherlands, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Estonia, Peru, Poland, France, Chile, Hungary, Italy, Slovakia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Slovakia, Poland, Belgium, Estonia, Hungary, Latvia, Lithuania, Turkey, Canada, India, Netherlands, Ukraine, Russian Federation, Malaysia, Japan, Thailand
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, Colombia, Korea, Republic of, Brazil, Hungary, Czech Republic, India, Slovakia, Peru
-
InflaRx GmbHQuintiles, Inc.CompletedHidradenitis Suppurativa (HS)United States, Bulgaria, Canada, Denmark, France, Germany, Greece, Netherlands, Poland
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Belgium, Hungary
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Hospital Clinic of BarcelonaUnknown
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
Novartis PharmaceuticalsCompletedCOPDGermany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
-
University of SaskatchewanCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Irmandade Santa Casa de Misericórdia de Porto AlegreNovartisCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Morten Hostrup, PhDRecruitingExercise PerformanceDenmark
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseItaly
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Netherlands, United Kingdom, China, Romania, Bulgaria
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseBelgium
-
Vanderbilt UniversityFresenius Medical Care North AmericaCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseChina, Argentina, Taiwan, Chile
-
United Arab Emirates UniversityTawam HospitalCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Centre Hospitalier Universitaire de BesanconCompletedChronic Obstructive Pulmonary DiseaseFrance
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Spain, Canada, United Kingdom
-
University of MilanFondazione Salvatore MaugeriCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseColombia, Italy, Switzerland, Argentina, United Kingdom, Mexico, Netherlands, Malaysia, Spain
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Laval UniversityNovartisCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseArgentina, Dominican Republic, Panama, Mexico, Brazil, Chile, Ecuador, Honduras
-
Novartis PharmaceuticalsRecruitingAsthmaItaly, Spain, Austria, Portugal, Argentina, South Africa, Greece, Hungary, Colombia, Mexico, Guatemala, Romania, Czechia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
Pearl Therapeutics, Inc.Completed
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedExtragonadal Germ Cell Tumor | Childhood Germ Cell TumorCanada, United States, Australia, Puerto Rico
-
Mundipharma Research LimitedTerminatedACOS (Fixed Airflow Obstruction and Elevated Eosinophils)Slovakia
-
Wouter H. van GeffenNovartis; University Medical Center GroningenCompleted
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Beijing Chest HospitalNational Medical Center for Infectious DiseasesRecruitingPulmonary Tuberculosis | Rifampicin-resistant TuberculosisChina
-
Novartis PharmaceuticalsCompletedCOPDIndia, South Africa, Egypt, Australia, Israel, Lebanon, Turkey, Philippines, Malaysia, Taiwan, Saudi Arabia
-
Chiesi Farmaceutici S.p.A.Withdrawn